Germany's Merck nears roughly $3.5 billion deal for SpringWorks, WSJ reports

Delist

-0.51%

-1.07%

-1.69%

SpringWorks Therapeutics SWTX	46.99	Delist
Dow Jones Industrial Average DJI	48458.05	-0.51%
S&P 500 index SPX	6827.41	-1.07%
NASDAQ IXIC	23195.17	-1.69%

April 24 (Reuters) - Germany's Merck KGaA MRCG.DE is nearing a roughly $3.5 billion deal for SpringWorks Therapeutics SWTX.O, the Wall Street Journal reported on Thursday, citing people familiar with the matter.

(Reporting by Sriparna Roy in Bengaluru; Editing by Alan Barona)

((Sriparna.Roy@thomsonreuters.com))

More This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.